KO-Validated CDK6 Recombinant Rabbit Monoclonal Antibody

Description

EnkiLife offers the KO-Validated CDK6 Recombinant Rabbit Monoclonal Antibody. This antibody reacts with Human and is suitable for WB,FCM,ICC application. The product boasts remarkable high specificity, outstanding reproducibility, and exceptional affinity, making it a reliable and superior choice for your needs. Dilution Ratio: WB 1:1,000-1:5,000; FC 1:200-1:2,000; ICC 1:100-1:1,000 Alternative Names of Immunogen:CDK6; Cyclin Dependent Kinase 6; PLSTIRE; Serine/Threonine-Protein Kinase PLSTIRE; Cell Division Protein Kinase 6; Cyclin-Dependent Kinase 6; EC 2.7.11.22; EC 2.7.11; MCPH12; CDKN6 Background: The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017] Research Area: Cell Biology,Epigenetics and Nuclear Signaling,Cancer